Aurora St. Luke’s Medical Center and its team of world-renowned heart experts recently reached a historic milestone at the ...

more commonly used valve in our institute, namely, the St Jude Medical Regent aortic mechanical prosthetic valve. This is ‘real life’ data from ‘all comers’ in our institute rather than selected group ...

Conclusions— Severe P-PtM is an independent predictor of higher long-term mortality and congestive heart failure in patients with small St Jude Medical aortic valve prostheses. For patients undergoing ...

Between March 1978 and December 1991, 988 patients underwent implantation of St. Jude ... valves were identified prospectively. During this period, 17 patients (13 women; mean age, 66.8 +/- 19.0 years ...

St Jude Medical X-Cell, and Carpentier-Edwards Perimount valves. This work was supported by grants from the Canadian Institutes of Health Research (MOP 57745), Ottawa, Canada. Dr Pibarot is the ...

Abbott’s Trifecta devices are intended to treat damaged or malfunctioning aortic heart valves. St. Jude Medical won approval for the first-generation Trifecta device in 2011 and launched its follow-up ...

Based on the published literature, the FDA is concerned that the rate of early deterioration may be higher for Trifecta than for other surgical aortic valve replacement (SAVR ... market through its ...

4D cine imaging of a St. Jude mechanical bileaflet prosthetic heart valve in the aortic position showing a fixed leaflet. Opening and closing angles of two St. Jude mechanical bileaflet prosthetic ...

St. Jude Medical today announced the U.S. launch of the Trifecta™ valve with Glide™ Technology for the treatment of patients diagnosed with unhealthy, ...

The new Trifecta™ Valve with Glide™ Technology offers improved options for patients in need of aortic valve replacement through an enhanced valve delivery designed to improve implantation ST. PAUL, ...